-
Atrial Fibrillation and the Prognostic Performance of Biomarkers in Heart FailureESJ Tan, S-P Chan, O-W Liew et al. -
Modifiable lifestyle factors and heart failure: A Mendelian randomization studyS van Oort, JWJ Beulens, AJ van Ballegooijen et al.
-
When and how to use SGLT2 inhibitors in patients with HFrEF or chronic kidney diseaseE O'Meara, S Verma.
-
Efficacy of Ertugliflozin on Heart Failure–Related Events in Patients With Type 2 Diabetes Mellitus and Established Atherosclerotic Cardiovascular Disease Results of the VERTIS CV TrialF Cosentino , CP Cannon , DZI Cherney et al.
-
Risk of Mortality Following Catheter Ablation of Atrial FibrillationEP Cheng, CF Liu, JW Cheung et al.
-
Dapagliflozin and Cardiovascular Outcomes in Type 2 DiabetesSD Wiviott，I Raz，DECLARE–TIMI 58 Investigators.
-
Unexpectedly Low Natriuretic Peptide Levels in Patients With Heart FailureKN Bachmann, DK Gupta , M Xu et al.
-
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel ConsensusD Farmakis, C Chrysohoou, G Giamouzis et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
